PUT - SPRINTER OPEN END - STRYKER CORP. Share Price

Certificat

DE000VM55EE4

Delayed Deutsche Boerse AG 19:04:24 28/05/2024 BST
6.24 EUR -1.42% Intraday chart for PUT - SPRINTER OPEN END - STRYKER CORP.
Current month-0.47%
3 months+30.79%
Date Price Change
28/05/24 6.24 -1.42%
27/05/24 6.33 -1.56%
24/05/24 6.43 -6.27%
23/05/24 6.86 +5.54%
22/05/24 6.5 -7.67%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 07:04 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM55EE
ISINDE000VM55EE4
Date issued 29/11/2023
Strike 404.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 10.52
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.85
Lowest since issue 4.14
Spread 0.04
Spread %0.64%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.5 USD
Average target price
372.4 USD
Spread / Average Target
+10.97%
Consensus